Nestlé recalled infant formula in more than 60 countries in January 2026 after cereulide, a toxin that can cause vomiting, was traced to an ingredient from an outside supplier. CEO Philipp Navratil apologized by video on January 13, but the consumer group Foodwatch said the apology came too late. Nestlé later booked CHF 185 million in 2025 recall costs. The case shows why the order and timing of disclosure shape how an apology is judged.
Nestlé detected very low levels of cereulide in product samples at the end of November 2025, during routine checks after new equipment was installed on a line at its Netherlands factory, according to Nestlé's own sequence of events. The company halted production, ran further lab analysis and received confirmation at the beginning of December.
The contamination was traced to arachidonic acid oil, known as ARA, from a global industry supplier. Nestlé said it informed the Dutch authorities on December 10, told the supplier on December 29, and alerted the industry through trade associations on December 30. The public recall followed in early January, and Reuters reported on January 6 that Nestlé was recalling batches of SMA, BEBA and NAN formula in 25 countries.
How far did the recall spread?
At least 53 countries across Europe, the Americas, Asia and Africa had issued health warnings by January 14, according to Reuters. Food Ingredients First later reported a recall spanning more than 60 countries and nearly 80 batches of SMA, BEBA, NAN and Alfamino products.
Austrian authorities described it as the largest product recall in the company's history, per Food Ingredients First. Vietnam ordered a halt to all sales of Nestlé's Beba and Alfamino powdered milk regardless of batch number. Danone, Hochdorf and Lactalis also recalled products over the same type of contaminated ARA oil, according to the same outlet.
What did Philipp Navratil's apology say?
Navratil posted a video apology on January 13 for the "worry and disruption" the recall caused parents, caregivers and customers, according to Reuters. He said there were no confirmed cases of illness linked to the recalled batches, confirmed a quality concern at a Netherlands factory in December, and said production had restarted using safe oil from another supplier.
The apology came about a week after the recall became public. It was also Navratil's first major crisis as CEO, since he was promoted in September 2025 after the dismissal of his predecessor, Laurent Freixe, per Food Ingredients First.
Why did Foodwatch call the apology inadequate?
Foodwatch director Nicole van Gemert said "An apology is not enough," according to Food Ingredients First, and argued parents needed clear information and warnings weeks earlier. The group demanded that Nestlé disclose when it knew about the contamination and why country-by-country warnings were delayed.
Foodwatch also claimed that nearly a month passed before the global public recall, per Food Ingredients First. Nestlé's own timeline shows detection in late November, regulator notice on December 10 and a public recall in January, so the disagreement is about when the public should have been told.
How did the "no confirmed illness" line hold up?
Nestlé maintained that no illness had been confirmed, while authorities in several countries reported cases under investigation. Brazilian health authorities confirmed two infants around one year old with persistent vomiting and diarrhea after consuming affected formula, per Food Ingredients First. French authorities were investigating the death of a baby who consumed Nestlé's Guigoz formula, and Singapore confirmed one case likely associated with cereulide exposure, according to the same outlet.
Critics told Food Ingredients First the "no confirmed cases" wording was technically defensible but structurally misleading, because causation is hard to prove. The sources reviewed describe the investigations as ongoing, so the claim should be read as Nestlé's position, not as a finding of fact.
What did Nestlé disclose about its own timeline?
Nestlé published a "Sequence of events" document dated January 29, 2026, about two weeks after the video apology. It laid out detection, lab confirmation, supplier and authority notices, and more than 400 samples tested at up to 60 analyses per day over the year-end holidays.
Publishing the timeline answered the question Foodwatch had asked in January, but it arrived after the criticism. A timeline released with the first statement would have framed the debate before critics did.
What did the recall cost Nestlé?
Nestlé booked CHF 185 million in its 2025 results for the recall, made up of CHF 75 million in estimated sales returns and CHF 110 million in inventory write-offs, according to Food Ingredients First. In the first quarter of 2026 the recall cut organic growth by about 90 basis points, and infant formula real internal growth fell 3.5%, per Nestlé's results.
CFO Anna Manz said infant formula sales were down about 10% and that Nestlé expected to recover fully by the end of the year, according to Just Food. Nestlé said product availability was back to normal. Its half-year 2026 results said market share in Nutrition remained affected, and that Nutrition sales declined across Europe because of the recall.
| Date | Event |
|---|
| End of November 2025 | Cereulide detected at the Netherlands factory |
| December 10, 2025 | Nestlé informs the Dutch authorities |
| December 29 to 30, 2025 | Supplier told; industry alerted through trade associations |
| January 6, 2026 | Public recall reported in 25 countries |
| January 13, 2026 | CEO video apology; Foodwatch criticizes it |
| January 21, 2026 | Lactalis recalls Picot batches across 18 countries |
| January 29, 2026 | Nestlé publishes its sequence of events |
| April 2026 | First-quarter results show a 90 basis point hit to organic growth |
What should brands learn from the Nestlé recall?
The case turns on the gap between when a company knows and when the public is told. Nestlé's internal sequence was orderly, but the public sequence started weeks later, and the apology got attached to that gap.
- Publish the internal timeline with the first public statement, not two weeks later.
- Align regulator notice, trade notice and consumer notice, and explain any difference in timing.
- Define "confirmed" in plain language when saying no illness has been confirmed.
- Tie the apology to a dated action, such as the supplier change and restart of production.
- Track trust recovery by market share, not only by shelf availability.
For another case where apology timing shaped the story, see Neutrogena and Hayden Panettiere. For apologies that held up, see corporate apology campaigns that worked, and for the wider playbook, crisis communications.
